Alexion Pharmaceuticals
Olaolu Oloyede is a Senior Manager of Market Access at Alexion Pharmaceuticals, Inc., with expertise in health economics and outcomes research developed through roles at Novartis as HEOR Manager and MSD as HTA and Outcomes Research Manager. Experience encompasses a range of positions, including Senior Pharmacist at the Department of Health and Social Care and Technology Appraisal Committee Member at NICE. Olaolu has contributed to public health initiatives as Chief Pharmaceutical Officer's Clinical Fellow at Public Health England and has led primary care strategy at Medway Clinical Commissioning Group. An educational background includes a Master of Public Health in Health Economics from the London School of Hygiene and Tropical Medicine and a Master of Pharmacy from UCL.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.